MyFinsight
Home
Blog
About
Contact
Download
Download image
Net change in cash
and cash...
-$13,475K
Stock-based compensation
$9,636K
Depreciation
$8,780K
Amortization of intangibles
$7,633K
Non-cash operating lease
expense
$1,720K
Accounts payable and
other liabilities
$718K
Other adjustments
$402K
Net cash used in
operating activities
-$8,137K
Net cash (used in)
provided by investing...
-$5,000K
Net cash (used in)
provided by financing...
-$338K
Canceled cashflow
$28,889K
Net loss
-$17,106K
Purchases of property and
equipment
$5,000K
Issuance of common stock,
net
-$338K
Accounts receivable, net
$8,182K
Accrued compensation
-$7,004K
Prepaid and other assets
$1,395K
Operating lease
liabilities
-$1,299K
Inventories
$1,271K
Deferred income tax
liabilities, net
$769K
Back
Back
Cash Flow
source: myfinsight.com
NEOGENOMICS INC (NEO)
NEOGENOMICS INC (NEO)